We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLMD icon
3676
Galmed Pharmaceuticals
GLMD
$4.63M
$35K ﹤0.01%
+56
New +$45.7K
HT
3677
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$35K ﹤0.01%
6,237
+2,653
+74% +$15.6K
PBFX
3678
DELISTED
PBF LOGISTICS LP
PBFX
$35K ﹤0.01%
+4,254
New +$40.1K
AMRN
3679
Amarin Corp
AMRN
$297M
$34K ﹤0.01%
399
+258
+183% +$30.9K
BSVN icon
3680
Bank7 Corp
BSVN
$495M
$34K ﹤0.01%
3,601
+2,711
+305% +$27.3K
EVOK
3681
DELISTED
Evoke Pharma
EVOK
$34K ﹤0.01%
+50
New +$31.9K
GOCO
3682
DELISTED
GoHealth
GOCO
$34K ﹤0.01%
+173
New +$41.7K
HYLB icon
3683
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
$34K ﹤0.01%
875
+500
+133% +$19.3K
LOGI icon
3684
Logitech
LOGI
$14.8B
$34K ﹤0.01%
+443
New +$31.7K
RNST icon
3685
Renasant Corp
RNST
$4B
$34K ﹤0.01%
1,491
-4,559
-75% -$110K
SGOL icon
3686
abrdn Physical Gold Shares ETF
SGOL
$7.42B
$34K ﹤0.01%
+1,900
New +$35K
RSX
3687
DELISTED
VanEck Russia ETF
RSX
$34K ﹤0.01%
1,637
-2,580
-61% -$56.8K
SCPE
3688
DELISTED
SC Health Corporation
SCPE
$34K ﹤0.01%
3,388
+1,500
+79% +$15.2K
QEP
3689
DELISTED
QEP RESOURCES, INC.
QEP
$34K ﹤0.01%
38,304
-95,871
-71% -$125K
ABCB icon
3690
Ameris Bancorp
ABCB
$5.94B
$33K ﹤0.01%
1,439
-6,758
-82% -$159K
ACIU icon
3691
AC Immune
ACIU
$267M
$33K ﹤0.01%
6,788
+14
+0.2% +$100
BANF icon
3692
BancFirst
BANF
$3.84B
$33K ﹤0.01%
809
-1,638
-67% -$69K
EWA icon
3693
iShares MSCI Australia ETF
EWA
$1.45B
$33K ﹤0.01%
1,652
-494
-23% -$10K
INZY
3694
DELISTED
Inozyme Pharma
INZY
$33K ﹤0.01%
+1,259
New +$31.3K
MANU icon
3695
Manchester United
MANU
$3.94B
$33K ﹤0.01%
2,301
-1,971
-46% -$30.1K
NTR icon
3696
Nutrien
NTR
$32.1B
$33K ﹤0.01%
839
-28,005
-97% -$1.02M
SPHB icon
3697
Invesco S&P 500 High Beta ETF
SPHB
$956M
$33K ﹤0.01%
787
-50,955
-98% -$2.14M
VERY
3698
DELISTED
Vericity, Inc. Common Stock
VERY
$33K ﹤0.01%
3,187
+460
+17% +$4.12K
FTCH
3699
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$33K ﹤0.01%
1,326
-5,172
-80% -$128K
IEA
3700
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$33K ﹤0.01%
5,472
+5,232
+2,180% +$22.6K
146 147
148
149 150

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.